Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats

Journal of Clinical Investigation

Volumn 98, Issue 2, 1996, Pages 317-324

  Janssens, Stefan P ^a,c   Bloch, Kenneth D ^b   Nong, Zengxuan ^a   Gerard, Robert D ^a   Zoldhelyi, Pierre ^a   Collen, Desire ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

adenovirus; gene therapy; guanylate cyclase; hypoxia; pulmonary hypertension

Indexed keywords

ARGININE; BETA GALACTOSIDASE; CITRULLINE; NITRIC OXIDE SYNTHASE;

ADENOVIRUS; AEROSOL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FETUS; GENE THERAPY; GENE TRANSFER; HYPOXIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LUNG ARTERY PRESSURE; LUNG VASOCONSTRICTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; TRANSGENE; VIRUS RECOMBINANT;

EID: 0030017320     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118795     Document Type: Article

References (43)

1. Vanhoutte, P.M. 1988. The endothelium-modulator of vascular smooth muscle tone. N. Engl. J. Med. 319:512-513.
2. Nathan, C. 1992. Nitric oxide as a secretory signal of mammalian cells. FASEB J. 6:3051-3064.
3. Nathan, C., and Q.W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:915-918.
4. Stuehr, D.J., and O.W. Griffith. 1992. Mammalian nitric oxide synthases. Adv. Enzymol. Relat. Areas Mol. Biol. 65:287-346.
5. Lowenstein, C.J., C.S. Glatt, D. Bredt, and S.H. Snyder. 1992. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. USA. 89:6711-6715.
6. Moncada, S., R.M. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
7. Garg, U.C., and A. Hassid. 1989. Nitric oxide-generating vasodilators and 8-hromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1774-1777.
8. Roberts, J.D., C.T. Roberts, R.C. Jones, W.M. Zapol, and K.D. Bloch. 1995. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ. Res. 76:215-222.
9. Heath, D. 1993. The pathology of pulmonary hypertension. Eur. Respir. Rev. 3:555-558.
10. Radomski, M.W., R.M.J. Palmer, and S. Moncada. 1987. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 148:1482-1489.
11. Assender, J.W., K.M. Southgate, and A.C. Newby. 1991. Does nitric oxide inhibit smooth muscle cell proliferation? J. Cardiovasc. Pharmacol. 17:104-107.
12. deGraaf, J.C., J.D. Banga, S. Moncada, R.M.J. Palmer, P.J. deGroot, and J.J. Sixma. 1992. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation. 85:2284-2290.
13. Adnot, S., B. Raffestin, S. Eddahibi, P. Braquet, and P. Chabrier. 1991. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest. 87:155-162.
14. Johns, R.A., J.M. Linden, and M.J. Peach. 1989. Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ. Res. 65:1508-1515.
15. Shaul, P.W., L.B. Wells, and K.M. Horning. 1993. Acute and prolonged hypoxia attenuate endothelial nitric oxide production in rat pulmonary arteries by different mechanisms. J. Cardiovasc. Pharmacol. 22:819-827.
16. McQuillan, L.P., G.K. Leung, P.A. Marsden, S.K. Kostyk, and S. Kourembanas. 1994. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am. J. Physiol. 267:H1921-H1927.
17. Giaid, A., and D. Saleh. 1995. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. M Engl. J. Med. 333:214-221.
18. Mastrangeli, A., C. Danel, M. Rosenfeld, L. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J. Lecocq, and R. Cristal. 1993. Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J. Clin. Invest. 91:225-234.
19. Hazinski, T.A., P.A. Ladd, and C.A. DeMatteo. 1991. Localization and induced expression of fusion genes in the rat lung. Am. J. Respir. Cell Mol. Biol. 4:206-209.
20. Stribling, R., E. Brunette, D. Liggitt, K. Gaensler, and R. Debs. 1992. Aerosol gene delivery in vivo. Proc. Natl. Acad. Sci. USA. 89:11277-11281.
21. Miller, D.G., M.A. Adam, and A.D. Miller, 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell Biol. 10:4239-4242.
22. Janssens, S.P., A. Shimouchi, T, Quertermous, D.B. Bloch, and K.D. Bloch. 1992. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267:14519-14522.
23. Gomez-Foix, A., W. Coats, S. Baque, T. Alam, R. Gerard, and C. Newgard. 1992. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J. Biol. Chem. 267:25129-25134.
24. Gerard, R., and R. Meidell. 1995. Adenovirus vectors in DNA cloning - a practical approach. In Mammalian Systems. B.D. Hames and D. Glover, editors, Oxford University Press, Oxford. In press.
25. Herz, J., and R.D. Gerard. 1993. Adenovirus-mediated transfer of the low density lipoprotein receptor gene acutely accelerates cholesterol clearance in mice. Proc. Natl. Acad. Sci. USA. 90:2812-2816.
26. Xue, C., A. Rengasamy, T.D.L. Cras, P.A. Koberna, G.C. Dailey, and R. A. Johns. 1994. Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am. J. Physiol. 267:L667-L678.
27. Janssens, S.P., B.T. Thompson, CR. Spence and C.A. Hales. 1994. Functional and structural changes with hypoxia in pulmonary circulation of spontaneously hypertensive rats. J. Appl. Physiol. 77:1101-1107.
28. Kawai, N., D.B. Bloch, G. Fillipov, D. Rabkina, H. Suen, P.D. Losty, S.P. Janssens, W.M. Zapol, S. de la Monte, and K.D. Bloch. 1995. Constitutive endothelial nitric oxide synthase gene expression is regulated during lung development. Am. J. Physiol. 268:L589-L595.
29. Archer, S.L., J.P. Tolins, L. Raij, and E.K. Weir. 1989. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem. Biophys. Res. Commun. 164:1198-1205.
30. Crawley, D.E., L. Zhao, M.A. Giembycz, S.F. Iiu, P.J. Barnes, R.J.D. Winter, and T.W. Evans. 1992. Chronic hypoxia impairs soluble guanylate cyclase-mediated pulmonary arterial relaxation in the rat. Am. J. Physiol. 263: L325-L332.
31. Fineman, J.R., R. Chang, and S.J. Soifer. 1992. EDRF inhibition augments pulmonary hypertension in intact newborn lambs. Am. J. Physiol. 262: H1365-H1371.
32. Dinh-Xuan, A.T., T.W. Higenbottam, C.A. Clelland, J. Pepke-Zaba, G. Cremona, A.Y. Butt, S.R. Large, F.C. Wells, and J. Wallwork. 1991. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 324:1539-1547.
33. Dinh-Xuan, A.T., J. Pepke-Zaba, A.Y. Butt, G. Cremona, and T.W. Higgenbottam. 1993. Impairment of pulmonary artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial membrane receptors nor to L-arginine deficiency. Br. J. Pharmacol. 109:587-591.
34. Christman, B.W., C.D. McPherson, and J.H. Newman. 1992. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 327:70-75.
35. Killbourn, R.G., S.S. Gross, J. Adams, A. Jubran, D.W. Griffith, R. Levi, and R.F. Lodato. 1990. L-NG-Methylarginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA. 87:3629-3632.
36. Sobol, B.J., G. Bottex, C. Emirgil, and H. Gissen. 1963. Gaseous diffusion from alveoli to pulmonary vessels of considerable size. Circ. Res 13:71-79.
37. Frostell, C., M. Fratacci, J.C. Wain, R. Jones, and W.M. Zapol. 1991. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 83:2038-2047.
38. Frostell, C., H. Blomqvist, G. Hedenstierna, J. Lundberg, and W.M. Zapol. 1993. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 78:427-435.
39. Rimar, S., and C.N. Gillis. 1993. Selective pulmonary vasodilatation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation. 88:2884-2887.
40. Pepke-Zaba, J., T.W. Higgenbottam, A.T. Dinh-Xuan, D. Stone, and J. Wallwork. 1991. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 338:1173-1174.
41. Girard, C., J. Lehot, J. Pannetier, S. Filley, P. French, and S. Estanove. 1992. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary hypertension. Anesthesiology. 77:880-883.
42. Roberts, J.D., D.M. Polaner, P. Lang, and W.M. Zapol. 1992. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 340: 818-819.
43. Rossaint, R., K.J. Falke, F. Lopez, K. Slama, U. Pison, and W.M. Zapol. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328:399-405.